Samuel A. Hamood - Oct 1, 2021 Form 3 Insider Report for Finch Therapeutics Group, Inc. (FNCH)

Role: Director
Signature: /s/ Sydney Gaylin, Attorney-in-Fact
Stock symbol: FNCH
Transactions as of: Oct 1, 2021
Transactions value $: $0
Form type: 3
Date filed: 10/5/2021, 07:49 PM
Previous filing: Sep 15, 2021
Next filing: May 26, 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

No securities beneficially owned. Exhibit List - Exhibit 24 - Power of Attorney